Palisade Asset Management, LLC Eli Lilly & CO Transaction History

Palisade Asset Management, LLC

$959 Million
Q1 2025

A detailed history of Palisade Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Palisade Asset Management, LLC holds 18,338 shares of LLY stock, worth $15.2 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares

18,338

Previous 19,058 3.78%

Holding current value

$15.2 Million

Previous $14.7 Million 2.94%

% of portfolio

1.58%

Previous 1.52%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 22, 2025	SELL	$725.72 - $929.72 $522,518 - $669,398	-720 Reduced 3.78%	18,338 $15.1 Million
Q4 2024 Feb 11, 2025	SELL	$727.2 - $932.06 $8,726 - $11,184	-12 Reduced 0.06%	19,058 $14.7 Million
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $124,314 - $154,563	-161 Reduced 0.84%	19,070 $16.9 Million
Q2 2024 Aug 01, 2024	SELL	$724.87 - $909.04 $2.38 Million - $2.98 Million	-3,278 Reduced 14.56%	19,231 $17.4 Million
Q1 2024 May 01, 2024	SELL	$592.2 - $792.28 $118,440 - $158,456	-200 Reduced 0.88%	22,509 $17.5 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $120,268 - $141,780	229 Added 1.02%	22,709 $13.2 Million
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $88,244 - $121,657	-203 Reduced 0.89%	22,480 $12.1 Million
Q1 2022 Apr 21, 2022	SELL	$234.69 - $291.66 $199,486 - $247,911	-850 Reduced 3.61%	22,683 $6.5 Million
Q4 2021 Feb 01, 2022	SELL	$224.85 - $279.04 $78,697 - $97,664	-350 Reduced 1.47%	23,533 $6.5 Million
Q2 2021 Jul 22, 2021	SELL	$180.55 - $233.54 $18,055 - $23,354	-100 Reduced 0.42%	23,883 $5.48 Million
Q1 2021 May 04, 2021	BUY	$164.32 - $212.72 $7,230 - $9,359	44 Added 0.18%	23,983 $4.48 Million
Q4 2020 Feb 03, 2021	SELL	$130.46 - $172.63 $13,046 - $17,263	-100 Reduced 0.42%	23,939 $4.04 Million
Q3 2020 Oct 26, 2020	SELL	$146.22 - $169.13 $146,220 - $169,130	-1,000 Reduced 3.99%	24,039 $3.56 Million
Q2 2020 Jul 27, 2020	SELL	$136.42 - $164.18 $85,262 - $102,612	-625 Reduced 2.44%	25,039 $4.11 Million
Q3 2019 Oct 16, 2019	SELL	$106.79 - $116.16 $28,833 - $31,363	-270 Reduced 1.04%	25,664 $2.87 Million
Q2 2019 Jul 25, 2019	SELL	$110.79 - $129.32 $47,085 - $54,961	-425 Reduced 1.61%	25,934 $2.87 Million
Q1 2019 Apr 15, 2019	BUY	$111.31 - $131.02 $111,310 - $131,020	1,000 Added 3.94%	26,359 $3.42 Million
Q3 2018 Oct 19, 2018	SELL	$85.86 - $107.31 $17,172 - $21,462	-200 Reduced 0.78%	25,359 $2.72 Million
Q1 2018 Apr 25, 2018	BUY	$74.21 - $87.6 $22,262 - $26,280	300 Added 1.19%	25,559 $1.98 Million
Q4 2017 Feb 01, 2018	BUY	$81.94 - $87.89 $303,178 - $325,193	3,700 Added 17.16%	25,259 $0
Q3 2017 Oct 26, 2017	BUY	$77.07 - $85.54 $1.66 Million - $1.84 Million	21,559	21,559 $1.84 Million

Others Institutions Holding LLY

# of Institutions

4,323

Shares Held

758M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $786B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Asset Management, LLC with notifications on news.

Account

Palisade Asset Management, LLC Eli Lilly & CO Transaction History